Pilot study by Brigham investigators finds that an innovative care-delivery program helped 81 percent of participants achieve blood pressure control in seven weeks
Hypertension, or high blood pressure, is a widespread clinical problem affecting nearly half of all adults. Despite the serious consequences that can result from hypertension, which puts patients at increased risk for heart attacks, strokes and other cardiovascular events, elevated blood pressures often remain untreated or undertreated for years, and the control rate for hypertension hovers at just 50 percent. Seeing opportunities for improvement, innovators and clinicians at Brigham and Women’s Hospital have developed a new home-based, care-delivery program aimed to improve hypertension control rates quickly and at significantly lower cost than traditional, office-based blood pressure programs. The new approach, piloted among 130 participants, helped 81 percent of patients bring their blood pressures under control in, on average, just seven weeks. The results of the pilot study are published this week in Clinical Cardiology.
“This is a striking result, especially given the very short time frame in which control was reached: an average of seven weeks,” said corresponding author Naomi Fisher, MD, director of the Hypertension Service and Hypertension Specialty Clinic at the Brigham. “There are a few notable health care systems that have matched or exceeded this control rate, but most clinical practices do not approach this rate of success.”
To overcome some of the challenges that clinical practices face, Fisher and colleagues combined several innovative strategies to create their program. Enrolled participants each received a Bluetooth-enabled blood pressure device that could automatically transmit the blood pressure measurements patients took at home into their electronic medical records. Patients had easy and frequent access to “patient navigators”–non-physicians who had been trained to use a clinical algorithm developed by hypertension specialists. The program enabled rapid assessment and medication dosage adjustments for the patients.
The pilot was conducted as a prospective cohort study. The team enrolled 130 patients whose blood pressure was uncontrolled (greater than 140/90 mmHg). Patients were recruited from two clinics to test efficacy in two settings: a Brigham primary care clinic (800 Huntington Ave.), and the Brigham’s Watkins Cardiovascular Clinic. All adults were eligible except pregnant women and those with advanced kidney disease. Enrolled patients were given a Bluetooth-enabled blood pressure device and taught how to use it. Patients were instructed to measure their blood pressure at home twice daily in duplicate. Medication adjustments were made every two weeks until home blood pressure was controlled at <135/85 mmHg.
The team’s next step will be to scale up the program to test its generalizability and sustainability. With this approach, the team anticipates significant cost effectiveness and cost savings, in addition to the prevention of cardiovascular events and death from treating hypertension more intensively in men and women.
“The time-honored model of treating hypertension via traditional visits to the doctor is neither effective nor sustainable,” said Fisher. “Development of innovative solutions to manage hypertension effectively and efficiently, and thus reduce the cardiovascular risk burden in larger populations, is critical. Organizations can and should develop and adopt innovative technologies to create sustainable solutions for the control of hypertension.”
The Latest on: Hypertension
via Google News
The Latest on: Hypertension
- Dramatic Rise in Hypertension-Related Deaths in the United Stateson March 20, 2020 at 11:49 am
There has been a dramatic rise in hypertension-related deaths in the United States between 2007 and 2017, a new study shows. The authors, led by Lakshmi Nambiar, MD, Larner College of Medicine, ...
- Coronavirus Warning: People With Hypertension Told To Be Extra Vigilanton March 20, 2020 at 6:53 am
Those with high blood pressure and a few other underlying conditions have been warned to take extra precautions during this pandemic situation.
- To Treat Pandemics, Start by Treating Hypertensionon March 19, 2020 at 4:00 pm
Controlling common ailments is the first step for low- and middle-income countries looking ahead to what comes after the coronavirus crisis. Try to relax. For decades, doctors recognized a handful of ...
- 4 Pulmonary Hypertension Programs Receive PHA's PHCC Accreditationon March 19, 2020 at 2:50 pm
SILVER SPRING, Md., March 19, 2020 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association (PHA) announces that Tufts Medical Center in Boston; Cleveland Clinic in Cleveland; University of ...
- US sees sharp increase in hypertension-related deathson March 19, 2020 at 7:19 am
While it typically has no symptoms, high blood pressure—or hypertension—has serious health consequences. Rates of deaths related to hypertension have risen by 72% and 20% in rural and urban areas of ...
- Hypertension Management Devices Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025on March 19, 2020 at 3:56 am
New York, March 19, 2020: The scope of the report includes a detailed study of Hypertension Management Devices Market with the reasons given for variations in the growth of the industry in certain ...
- What People With Pulmonary Hypertension Should Know About COVID-19on March 16, 2020 at 11:01 am
and gives specific advice for the pulmonary hypertension community. My name is Roham Zamanian. I’m the medical director of the Adult Pulmonary Hypertension Program at Stanford University Medical ...
- A Doctor Shares How COVID-19 May Impact Pulmonary Hypertension Patientson March 16, 2020 at 10:57 am
Victor F. Tapson, M.D., from Cedars-Sinai discusses the coronavirus (COVID-19) and how it might impact pulmonary hypertension patients.
- Pulmonary Arterial Hypertension Treatment Market Future Investment and Forecast 2029 | GlaxoSmithKline plc and Eli Lilly and Companyon March 13, 2020 at 3:26 am
Market.us, Recently Published Report on “Pulmonary Arterial Hypertension Treatment Market Moving Towards 2020 With New Procedures, Provides Exhaustive PEST Analysis by 2029 | North America, Europe, ...
- Effects of Hypertension, Diabetes, and Smoking on Age and Sex Prediction from Retinal Fundus Imageson March 12, 2020 at 3:25 am
Every RGB channel of each input image was normalised to a z-score 31. This ensures the classification results to be invariant of intensities and colour contrasts of the images, thereby enabling the ...
via Bing News